• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "Long-term Safety and Tolerability of Omadacycline for the Treatment of Infections".

作者信息

Srivastava Shashikant, Gumbo Tawanda

机构信息

Department of Medicine, University of Texas School of Medicine, Tyler, Texas, USA.

Department of Cellular and Molecular Biology, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.

出版信息

Open Forum Infect Dis. 2023 Aug 7;10(8):ofad423. doi: 10.1093/ofid/ofad423. eCollection 2023 Aug.

DOI:10.1093/ofid/ofad423
PMID:37577111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10416810/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd2/10416810/ccd1f415d42f/ofad423f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd2/10416810/ccd1f415d42f/ofad423f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd2/10416810/ccd1f415d42f/ofad423f1.jpg

相似文献

1
Comment on "Long-term Safety and Tolerability of Omadacycline for the Treatment of Infections".关于“奥马环素治疗感染的长期安全性和耐受性”的评论
Open Forum Infect Dis. 2023 Aug 7;10(8):ofad423. doi: 10.1093/ofid/ofad423. eCollection 2023 Aug.
2
Omadacycline for the Treatment of Disease: A Case Series.奥马环素治疗疾病：病例系列
Open Forum Infect Dis. 2020 Sep 9;7(10):ofaa415. doi: 10.1093/ofid/ofaa415. eCollection 2020 Oct.
3
Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria.替加环素、依拉环素、奥马环素和沙雷环素对快速生长分枝杆菌的抗菌活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0323822. doi: 10.1128/spectrum.03238-22. Epub 2022 Dec 8.
4
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.奥马环素作为一种有前途的新型药物，可用于治疗脓肿分枝杆菌感染。
J Antimicrob Chemother. 2019 Oct 1;74(10):2930-2933. doi: 10.1093/jac/dkz267.
5
Safety and tolerability of long-term use of omadacycline in the treatment of infections.奥马环素长期用于治疗感染的安全性和耐受性。
IDCases. 2023 Jul 5;33:e01843. doi: 10.1016/j.idcr.2023.e01843. eCollection 2023.
6
Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.奥马环素对非结核分枝杆菌的药敏试验。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01947-20.
7
Correction to: Long-term Safety and Tolerability of Omadacycline for the Treatment of Infections.《奥马环素治疗感染的长期安全性和耐受性》的勘误
Open Forum Infect Dis. 2023 Aug 22;10(8):ofad446. doi: 10.1093/ofid/ofad446. eCollection 2023 Aug.
8
Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use.奥马环素治疗脓肿分枝杆菌感染：有效性评价、治疗地位及应用考量。
BMC Infect Dis. 2022 Nov 22;22(1):874. doi: 10.1186/s12879-022-07857-7.
9
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates and in a Mouse Model of Pulmonary Infection.奥马环素对脓肿分枝杆菌临床分离株的效价及肺部感染小鼠模型的疗效。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0170421. doi: 10.1128/AAC.01704-21. Epub 2021 Oct 18.
10
Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of .新型四环素类似物奥马环素和依拉环素对.耐药临床分离株的活性
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00470-19. Print 2019 Jun.

引用本文的文献

1
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant in the hollow fiber system model.奥马环素的药代动力学/药效学及在中空纤维系统模型中对多重耐药菌的疗效。
Antimicrob Agents Chemother. 2024 Feb 7;68(2):e0108023. doi: 10.1128/aac.01080-23. Epub 2023 Dec 22.

本文引用的文献

1
Long-term Safety and Tolerability of Omadacycline for the Treatment of Infections.奥马环素治疗感染的长期安全性和耐受性
Open Forum Infect Dis. 2023 Jul 3;10(7):ofad335. doi: 10.1093/ofid/ofad335. eCollection 2023 Jul.
2
Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.奥马环素在中空纤维模型中的药代动力学/药效学及治疗肺部脓肿分枝杆菌病的疗效临床验证。
Int J Antimicrob Agents. 2023 Jul;62(1):106847. doi: 10.1016/j.ijantimicag.2023.106847. Epub 2023 May 13.
3
Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
奥马环素在中空纤维系统模型中治疗肺部鸟分枝杆菌复合群的疗效和临床可达到的剂量下的效力。
J Antimicrob Chemother. 2022 May 29;77(6):1694-1705. doi: 10.1093/jac/dkac068.
4
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates and in a Mouse Model of Pulmonary Infection.奥马环素对脓肿分枝杆菌临床分离株的效价及肺部感染小鼠模型的疗效。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0170421. doi: 10.1128/AAC.01704-21. Epub 2021 Oct 18.
5
Preliminary, Real-world, Multicenter Experience With Omadacycline for Infections.奥马环素治疗感染的初步、真实世界、多中心经验
Open Forum Infect Dis. 2021 Jan 7;8(2):ofab002. doi: 10.1093/ofid/ofab002. eCollection 2021 Feb.
6
Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.奥马环素对非结核分枝杆菌的药敏试验。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01947-20.
7
Omadacycline for the Treatment of Disease: A Case Series.奥马环素治疗疾病：病例系列
Open Forum Infect Dis. 2020 Sep 9;7(10):ofaa415. doi: 10.1093/ofid/ofaa415. eCollection 2020 Oct.
8
Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill.重新利用药物治疗脓肿分枝杆菌：一种有希望的治疗方法。
J Antimicrob Chemother. 2020 May 1;75(5):1212-1217. doi: 10.1093/jac/dkz523.
9
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.系统评价和荟萃分析化疗对肺部脓肿分枝杆菌结局和疾病复发的影响。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01206-17. Print 2017 Nov.
10
Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.比较奥马环素和替加环素在健康成年受试者血浆、上皮衬液和肺泡细胞中的药代动力学。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.01135-17. Print 2017 Sep.